InvestorsHub Logo
icon url

JB3729

03/10/16 11:52 AM

#56121 RE: speramus #56090

Thanks. I hadn't thought about this and I agree -

I thought it would be much more difficult to get approval if Anavex 2-73 has to ride the shoulders of donepezil, JMO.



A2-73 looks to be a very powerful Alz drug on its own. This should bode well for the use of A2-73 against a myriad of other CNS diseases.